| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.005 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |